UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037021
Receipt number R000042176
Scientific Title Effects of respiratory rehabilitation on dynamic lung hyperinflation evaluated by hyperventilation in chronic obstructive pulmonary disease, an open label, randomized study
Date of disclosure of the study information 2019/06/13
Last modified on 2022/04/19 09:18:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of respiratory rehabilitation on dynamic lung hyperinflation evaluated by hyperventilation in chronic obstructive pulmonary disease

Acronym

Effect of rehabilitation on dynamic lung hyperinflation by hyperventilation study

Scientific Title

Effects of respiratory rehabilitation on dynamic lung hyperinflation evaluated by hyperventilation in chronic obstructive pulmonary disease, an open label, randomized study

Scientific Title:Acronym

Effect of rehabilitation on dynamic lung hyperinflation by hyperventilation study

Region

Japan


Condition

Condition

chronic obstructive pulmonary disease

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study is performed to elucidate the effects of respiratory rehabilitation for dynamic lung hyperinflation evaluated by hyperventilation in chronic obstructive pulmonary disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is defined as decrease in IC from rest by metronome-paced incremental hyperventilation (MPIH), which is an index of DLH.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Respiratory rehabilitation: The contents are shown below

1. 5 types of respiratory muscle stretch
Number of times:1 time or more / day

2. Inspiratory muscle training
Equipment used:POWER breathe PLUS
Number of times:30 times /2 sets / day and daily

3. aerobic exercise by walking (method of American Association of Cardiovascular Respiratory Rehabilitation)
Load:exercise load of up to 60% or more of the maximum exercise load (Work rate) obtained from the incremental load test, the subject is instructed to exercise 60% and exercise walking with reference to the Borg scale.
Number of times:20 minutes/day /3-5 times/week

Interventions/Control_2

Regular medication prescribed by a doctor

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

COPD patient group ( those who meet all the following criteria)

1. Patients diagnosed with COPD with 45 years of age or older (Global Initiative for Chronic Obstructive Lung Disease, 2019 report)

2. Patients who visited Shinshu University Hospital for the purpose of diagnosis and treatment of COPD

3. Patients who obtained informed consent for this study

4. Include asthma-COPD overlap syndrome

5. Patients who can go to the hospital once a month (every 4 weeks)

Key exclusion criteria

1. Patients who suffered from exacerbation or respiratory infection within 3 months from the time of obtaining consent

2. Patients who have difficulty in walking or filling in questionnaires due to the effects of motor function or cognitive function

3. Patients who have complications such as severe heart failure

4. Other patients who the research director judged inappropriate as a subject

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Shohei
Middle name
Last name Kawachi

Organization

Shinshu University

Division name

Graduate school of medicine science and technology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto sity, Nagano, Japan

TEL

0263372393

Email

18hm205e@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Shohei
Middle name
Last name Kawachi

Organization

Shinshu University

Division name

Graduate school of medicine science and technology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto sity, Nagano, Japan

TEL

0263-37-2393

Homepage URL


Email

18hm205e@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University, Graduate school of medicine science and technology

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Medical Ethics Committee

Address

3-1-1, Asahi, Matsumoto sity, Nagano, Japan

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2019 Year 06 Month 07 Day

Date of IRB

2019 Year 06 Month 07 Day

Anticipated trial start date

2019 Year 06 Month 07 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 11 Day

Last modified on

2022 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042176


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name